| | |
Hyperglycemic subjects (n = 50)
|
|---|
| | |
TEST (10:1)
|
TEST (15:1)
|
TEST (20:1)
|
Control
|
|---|
|
insulina
|
0 min
|
10.0 ± 0.77
|
10.4 ± 1.13
|
10.9 ± 1.39
|
9.5 ± 0.57
|
|
uIU/mL
|
15 min
|
15.2 ± 1.41
|
16.4 ± 1.57
|
17.5 ± 1.95
|
21.6 ± 1.75
|
| |
30 min
|
24.5 ± 2.31
|
24.6 ± 2.72
|
25.2 ± 2.48
|
33.3 ± 3.19
|
| |
60 min
|
30.8 ± 2.80
|
29.5 ± 3.41
|
33.7 ± 3.74
|
35.7 ± 4.46
|
| |
120 min
|
19.7 ± 3.59
|
20.2 ± 3.48
|
21.7 ± 4.36
|
16.1 ± 2.74
|
|
insulin AUCa (uIU/mLxhr)
|
47.2 ± 4.69
|
46.9 ± 5.34
|
51.8 ± 6.24
|
53.9 ± 5.58
|
|
C-peptidea
|
0 min
|
2.43 ± 0.13
|
2.40 ± 0.14
|
2.53 ± 0.16
|
2.42 ± 0.12
|
|
(ng/mLxhr
|
15 min
|
3.12 ± 0.14
|
3.21 ± 0.14
|
3.39 ± 0.17
|
3.72 ± 0.19
|
| |
30 min
|
4.30 ± 0.22
|
4.31 ± 0.23
|
4.52 ± 0.20
|
5.15 ± 0.27
|
| |
60 min
|
5.87 ± 0.27
|
5.89 ± 0.30
|
6.37 ± 0.29
|
6.51 ± 0.39
|
| |
120 min
|
5.32 ± 0.31
|
5.48 ± 0.31
|
5.66 ± 0.32
|
4.78 ± 0.31
|
|
C-peptide AUCa (ng/mLxhr)
|
9.76 ± 0.44
|
9.87 ± 0.46
|
10.46 ± 0.46
|
10.44 ± 0.53
|
- Mean ± SEM. Tested by ANOVA (Bonferroni)
-
aAnalyzed after log transformation
